US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 14.980
  • 0.0000.00%
Close Jul 19 16:00 ET
1.31BMarket Cap-5992P/E (TTM)

About Day One Biopharmaceuticals Company

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolDAWN
Company NameDay One Biopharmaceuticals
Listing DateMay 27, 2021
Issue Price16.00
Founded2018
CEODr. Jeremy Bender
MarketNASDAQ
Employees155
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address395 Oyster Point Boulevard,Suite 217
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-484-0899
Websitehttp://www.dayonebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeremy Bender
  • Chief Executive Officer, President and Director
  • 6.91M
  • Adam Dubow
  • General Counsel and Chief Compliance Officer
  • 2.77M
  • Charles N. York, II
  • Principal Accounting Officer, Chief Operating Officer, Chief Financial Officer and Secretary
  • 3.55M
  • Garry A. Nicholson
  • Chairman of the Board
  • 383.38K
  • Dr. William Grossman
  • Director
  • --
  • Habib Joseph Dable
  • Director
  • --
  • Dr. John A. Josey, PhD
  • Independent Director
  • 350.75K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 351.75K
  • Natalie C. Holles
  • Lead Independent Director
  • 352.50K
  • Scott Garland
  • Independent Director
  • 342.88K
  • Michael Gladstone
  • Independent Director
  • 342.88K
  • Dr. Samuel Blackman, M.D.
  • Head of Research and Development
  • 2.49M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg